[go: up one dir, main page]

ATE205542T1 - Vergleichende genomhybridisierung - Google Patents

Vergleichende genomhybridisierung

Info

Publication number
ATE205542T1
ATE205542T1 AT93907077T AT93907077T ATE205542T1 AT E205542 T1 ATE205542 T1 AT E205542T1 AT 93907077 T AT93907077 T AT 93907077T AT 93907077 T AT93907077 T AT 93907077T AT E205542 T1 ATE205542 T1 AT E205542T1
Authority
AT
Austria
Prior art keywords
subject
nucleic acid
sequences
genomes
copy numbers
Prior art date
Application number
AT93907077T
Other languages
German (de)
English (en)
Inventor
Daniel Pinkel
Joe W Gray
Anne Kallioniemi
Olli Pekka Kallioniemi
Frederic Waldman
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE205542T1 publication Critical patent/ATE205542T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT93907077T 1992-03-04 1993-03-01 Vergleichende genomhybridisierung ATE205542T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84665992A 1992-03-04 1992-03-04
US96994892A 1992-10-30 1992-10-30
PCT/US1993/001775 WO1993018186A1 (fr) 1992-03-04 1993-03-01 Hybridation genomique comparative

Publications (1)

Publication Number Publication Date
ATE205542T1 true ATE205542T1 (de) 2001-09-15

Family

ID=27126656

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93907077T ATE205542T1 (de) 1992-03-04 1993-03-01 Vergleichende genomhybridisierung

Country Status (8)

Country Link
US (3) US5665549A (fr)
EP (2) EP1134293A3 (fr)
JP (1) JP3645903B2 (fr)
AT (1) ATE205542T1 (fr)
CA (1) CA2131543C (fr)
DE (1) DE69330750T2 (fr)
ES (1) ES2161715T3 (fr)
WO (1) WO1993018186A1 (fr)

Families Citing this family (265)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721098A (en) * 1986-01-16 1998-02-24 The Regents Of The University Of California Comparative genomic hybridization
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
AU647741B2 (en) * 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining
US6025126A (en) 1991-10-28 2000-02-15 Arch Development Corporation Methods and compositions for the detection of chromosomal aberrations
US7534567B2 (en) 1992-03-04 2009-05-19 The Regents Of The University Of California Detection of nucleic acid sequence differences by comparative genomic hybridization
US5965362A (en) * 1992-03-04 1999-10-12 The Regents Of The University Of California Comparative genomic hybridization (CGH)
JP3645903B2 (ja) * 1992-03-04 2005-05-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 比較ゲノムハイブリダイゼーション（ｃｇｈ）
US5472842A (en) * 1993-10-06 1995-12-05 The Regents Of The University Of California Detection of amplified or deleted chromosomal regions
DE4344726C2 (de) * 1993-12-27 1997-09-25 Deutsches Krebsforsch Verfahren zum Nachweis von nicht balanciertem genetischen Material einer Spezies oder zum Nachweis der Genexpression in Zellen einer Spezies
US5962332A (en) * 1994-03-17 1999-10-05 University Of Massachusetts Detection of trinucleotide repeats by in situ hybridization
US7258983B2 (en) 1994-04-25 2007-08-21 Genentech, Inc. Cardiotrophin-1 compositions and methods for the treatment of tumor
US6472585B1 (en) 1994-04-25 2002-10-29 Genentech, Inc. Cardiotrophin-1 defective mouse
US7323298B1 (en) 1994-06-17 2008-01-29 The Board Of Trustees Of The Leland Stanford Junior University Microarray for determining the relative abundances of polynuceotide sequences
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US7378236B1 (en) 1994-06-17 2008-05-27 The Board Of Trustees Of The Leland Stanford Junior University Method for analyzing gene expression patterns
US5795716A (en) * 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5635351A (en) * 1995-03-14 1997-06-03 The Regents Of The University Of California Genetic gain and loss in gliomas
US5690894A (en) 1995-05-23 1997-11-25 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US6107033A (en) * 1995-07-28 2000-08-22 Rijksuniversiteit Groningen Methods and materials for determining relative abundance of microorganisms in mixed populations
US20040175718A1 (en) * 1995-10-16 2004-09-09 Affymetrix, Inc. Computer-aided visualization and analysis system for sequence evaluation
US7455964B1 (en) 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
US7049424B2 (en) 1996-07-15 2006-05-23 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
US5801021A (en) * 1995-10-20 1998-09-01 The Regents Of The University Of California Amplifications of chromosomal region 20q13 as a prognostic indicator in breast cancer
JP2000500021A (ja) * 1995-11-13 2000-01-11 アンスティテュ、パストゥール コームドｄｎａ繊維との超高解析度比較核酸ハイブリッド形成
ATE264922T1 (de) * 1995-12-22 2004-05-15 Exact Sciences Corp Verfahren zur erkennung von klonalen populationen von transformierten zellen in einer genomisch heterogenen zellulären probe
US5837196A (en) * 1996-01-26 1998-11-17 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
FR2755149B1 (fr) * 1996-10-30 1999-01-15 Pasteur Institut Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic
FR2755147B1 (fr) * 1996-10-30 1999-01-15 Pasteur Institut Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic
GB9704054D0 (en) 1997-02-27 1997-04-16 Univ Cambridge Tech Assay
CA2284481A1 (fr) * 1997-03-24 1998-10-01 Smithkline Beecham Corporation Procede de realisation d'echantillotheque soustractive
EP0878552A1 (fr) 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Détection moléculaire d'aberration chromosomique
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
DE19743301A1 (de) * 1997-09-30 1999-04-01 Metasystems Hard & Software Gm Verfahren zum Vergleich der Kopienzahl von Nukleinsäuresequenzen
US20050084875A1 (en) * 1997-10-24 2005-04-21 University Of Rochester Molecular markers for the diagnosis of Alzheimer's disease
AU753505B2 (en) * 1997-10-30 2002-10-17 Cold Spring Harbor Laboratory Probe arrays and methods of using probe arrays for distinguishing DNA
US6358749B1 (en) 1997-12-02 2002-03-19 Ozo Diversified Automation, Inc. Automated system for chromosome microdissection and method of using same
AU761272B2 (en) * 1998-01-12 2003-05-29 Newbiotics, Inc. Compositions and methods for treating cells having double minute DNA
US6289229B1 (en) 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
US6673914B1 (en) 1998-01-22 2004-01-06 John Wayne Cancer Institute Human tumor-associated gene
PT957176E (pt) * 1998-02-16 2006-09-29 Metasystems Hard & Software Gm Processo para a deteccao de modificacoes em biopolimeros
CA2321986A1 (fr) * 1998-02-25 1999-09-02 Sumitomo Electric Industries, Ltd. Procede de diagnostique du cancer basee sur la detection d'anomalie de chromosome
US6183957B1 (en) 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
JP2002513587A (ja) 1998-05-04 2002-05-14 ダコ エー エス 染色体異常を検出するための方法およびプローブ
US6979728B2 (en) 1998-05-04 2005-12-27 Baylor College Of Medicine Articles of manufacture and methods for array based analysis of biological molecules
US7901887B2 (en) 1998-05-09 2011-03-08 Ikonisys, Inc. Automated cancer diagnostic methods using fish
KR100691043B1 (ko) 1998-05-09 2007-03-09 아이코니시스 인코포레이티드 컴퓨터 제어된 태아 세포 포함 희귀 세포 진단 방법 및 장치
US20020001800A1 (en) * 1998-08-14 2002-01-03 Stanley N. Lapidus Diagnostic methods using serial testing of polymorphic loci
JP5213202B2 (ja) * 1998-10-28 2013-06-19 バイシス・インコーポレーテツド 細胞アレイならびに遺伝障害マーカーの検出および使用方法
WO2000026415A2 (fr) * 1998-11-02 2000-05-11 The Brigham & Women's Hospital, Inc. Technique d'hybridation genomique soustractive
WO2000031298A1 (fr) * 1998-11-23 2000-06-02 Exact Laboratories, Inc. Procedes servant a detecter des molecules de frequence inferieure
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
US6387618B1 (en) * 1999-03-03 2002-05-14 The United States Of America As Represented By The Secretary Of The Navy Micronucleus assay with genomic DNA hybridization probe and enzymatic color pigment detection
US6174681B1 (en) 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer
AU767983B2 (en) 1999-04-09 2003-11-27 Esoterix Genetic Laboratories, Llc Methods for detecting nucleic acids indicative of cancer
US6465182B1 (en) 1999-04-29 2002-10-15 The Regents Of The University Of California Comparative fluorescence hybridization to oligonucleotide microarrays
AU6350800A (en) * 1999-07-19 2001-02-05 American Laboratory Technologies, Inc. Removing repetitive sequences from dna
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6524794B1 (en) * 1999-10-29 2003-02-25 Decode Genetics Ehf. Identical-by-descent fragment enrichment
US6613516B1 (en) 1999-10-30 2003-09-02 Affymetrix, Inc. Preparation of nucleic acid samples
WO2001037192A1 (fr) * 1999-11-18 2001-05-25 Ikonisys, Inc. Procede et appareil, commandes par ordinateur, pour le diagnostic en fonction d'une cellule
DE60043896D1 (de) 1999-12-07 2010-04-08 Exact Sciences Corp Verfahren zum nachweis von lungenneoplasmen in fäkalen proben
US6919174B1 (en) 1999-12-07 2005-07-19 Exact Sciences Corporation Methods for disease detection
CA2397772C (fr) * 2000-01-12 2007-06-12 Ventana Medical Systems, Inc. Procede de determination d'une reaction a une therapie anticancereuse
AU785055B2 (en) 2000-01-13 2006-09-07 Genentech Inc. Novel stra6 polypeptides
AU9519601A (en) * 2000-05-02 2001-11-12 Centre National De La Recherche Scientifique Identification of genetic markers
US20020006622A1 (en) * 2000-06-07 2002-01-17 Allan Bradley Novel compositions and methods for array-based nucleic acid hybridization
US20030087286A1 (en) * 2000-09-06 2003-05-08 Hodge Timothy A. Isolation of eukaryotic genomic DNA using magnetically responsive solid functionalized particles
US7494817B2 (en) * 2000-09-06 2009-02-24 Transnet Yx, Inc. Methods for genotype screening using magnetic particles
US20050239125A1 (en) * 2000-09-06 2005-10-27 Hodge Timothy A Methods for genotype screening
US7011943B2 (en) 2000-09-06 2006-03-14 Transnetyx, Inc. Method for detecting a designated genetic sequence in murine genomic DNA
US20050266494A1 (en) * 2000-09-06 2005-12-01 Hodge Timothy A System and method for computer network ordering of biological testing
US20030082605A1 (en) * 2000-09-06 2003-05-01 Hodge Timothy A. Genomic DNA detection method and system thereof
US20050272085A1 (en) * 2000-09-06 2005-12-08 Hodge Timothy A Methods for forensic and congenic screening
WO2002044411A1 (fr) * 2000-12-01 2002-06-06 Rosetta Inpharmatics, Inc. Utilisation de profils dans la detection de l'aneuploidie
US20020142305A1 (en) * 2001-03-27 2002-10-03 Koei Chin Methods for diagnosing and monitoring ovarian cancer by screening gene copy numbers
US20040161741A1 (en) * 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US20060014186A1 (en) * 2001-09-04 2006-01-19 Hodge Timothy A Methods for genotype screening of a strain disposed on an adsorbent carrier
AU2002367886B8 (en) * 2001-10-12 2008-08-14 Perkinelmer Las, Inc. Compilations of nucleic acids and arrays and methods of using them
US7439346B2 (en) 2001-10-12 2008-10-21 Perkinelmer Las Inc. Nucleic acids arrays and methods of use therefor
US20030082618A1 (en) * 2001-10-15 2003-05-01 Guangshan Li Methods for detecting genetic aberrations
CA2467629A1 (fr) * 2001-11-20 2003-05-30 Oncomedx, Inc. Procedes pour evaluer une expression genique de resistance aux medicaments chez un patient atteint d'un cancer
US20030124542A1 (en) * 2001-12-28 2003-07-03 Spectral Genomics, Inc. Methods for mapping the chromosomal loci of genes expressed by a cell
US6916621B2 (en) 2002-03-27 2005-07-12 Spectral Genomics, Inc. Methods for array-based comparitive binding assays
AU2003224978A1 (en) * 2002-04-12 2003-10-27 Curators Of The University Of Missouri ECIST microarrays for dual screening of DNA hypermethylation and gene silencing
US20040005614A1 (en) * 2002-05-17 2004-01-08 Nurith Kurn Methods for fragmentation, labeling and immobilization of nucleic acids
KR20050004914A (ko) 2002-06-07 2005-01-12 제넨테크, 인크. 종양의 진단 및 치료 방법 및 이를 위한 조성물
US9388459B2 (en) 2002-06-17 2016-07-12 Affymetrix, Inc. Methods for genotyping
NL1021160C2 (nl) * 2002-07-26 2004-01-27 Multigen Internat B V Werkwijze voor het bepalen van het kopieaantal van een nucleotidevolgorde.
US7011949B2 (en) * 2002-09-30 2006-03-14 Agilent Technologies, Inc. Methods and compositions for producing labeled probe nucleic acids for use in array based comparative genomic hybridization applications
US7822555B2 (en) 2002-11-11 2010-10-26 Affymetrix, Inc. Methods for identifying DNA copy number changes
JP2006519977A (ja) * 2002-11-11 2006-08-31 アフィメトリックス インコーポレイテッド Ｄｎａコピー数変化を同定するための方法
US10229244B2 (en) 2002-11-11 2019-03-12 Affymetrix, Inc. Methods for identifying DNA copy number changes using hidden markov model based estimations
EP1576192B1 (fr) 2002-12-23 2014-10-29 Agilent Technologies, Inc. Essais comparatifs d'hybridation de genomes utilisant des oligonucleotides immobilises, et compositions permettant de les mettre en oeuvre
US7750908B2 (en) 2003-04-04 2010-07-06 Agilent Technologies, Inc. Focus plus context viewing and manipulation of large collections of graphs
US20040219532A1 (en) * 2003-04-30 2004-11-04 Sampson Jeffrey R. Internal references measurements
BRPI0410636A (pt) * 2003-05-23 2006-07-18 Cold Spring Harbor Lab representação virtual de seqüências de nucleotìdeo
US7211384B2 (en) * 2003-05-28 2007-05-01 Agilent Technologies, Inc. Comparative genomic hybridization assays using immobilized oligonucleotide targets with initially small sample sizes and compositions for practicing the same
WO2005012500A2 (fr) * 2003-08-01 2005-02-10 Spectral Genomics, Inc. Jeux ordonnes d'echantillons, procedes et kits de preparation et d'utilisation de jeux ordonnes d'echantillons genomiques synteniques pour l'etablissement de diagnostics et la toxicologie
AU2004286845A1 (en) * 2003-10-30 2005-05-19 Tufts-New England Medical Center Prenatal diagnosis using cell-free fetal DNA in amniotic fluid
CA2552007A1 (fr) 2003-12-29 2005-07-21 Nugen Technologies, Inc. Methodes permettant d'analyser l'etat de methylation d'acides nucleiques et methodes permettant de fragmenter, de marquer et d'immobiliser des acides nucleiques
US20060084067A1 (en) * 2004-02-03 2006-04-20 Zohar Yakhini Method and system for analysis of array-based, comparative-hybridization data
WO2005079474A2 (fr) 2004-02-17 2005-09-01 The Regents Of The University Of California Detection de differences de sequences d'acide nucleique par hybridation genomique comparative
US20070031883A1 (en) * 2004-03-04 2007-02-08 Kincaid Robert H Analyzing CGH data to identify aberrations
US8321138B2 (en) 2005-07-29 2012-11-27 Agilent Technologies, Inc. Method of characterizing quality of hybridized CGH arrays
US20050233339A1 (en) * 2004-04-20 2005-10-20 Barrett Michael T Methods and compositions for determining the relationship between hybridization signal of aCGH probes and target genomic DNA copy number
US20050233338A1 (en) * 2004-04-20 2005-10-20 Barrett Michael T Methods and compositions for assessing chromosome copy number
WO2005113834A2 (fr) * 2004-05-20 2005-12-01 Quest Diagnostics Investments Incorporated Hybridation comparative a marqueur unique
WO2006002191A1 (fr) * 2004-06-21 2006-01-05 Nimblegen Systems, Inc. Methodes d'optimisation de sondes
JP4476050B2 (ja) * 2004-06-30 2010-06-09 株式会社ニデック 視野計
EP1789786A4 (fr) * 2004-08-18 2008-02-13 Abbott Molecular Inc Détermination de qualité de données et/ou d'aneusomie segmentaire à l'aide d'un système informatique
US20060078899A1 (en) * 2004-10-12 2006-04-13 Scheffer Alicia F Methods and compositions for reducing label variation in array-based comparative genome hybridization assays
US20060080043A1 (en) * 2004-10-12 2006-04-13 Sampas Nicholas M Comparative genomic hybridization significance analysis using data smoothing with shaped response functions
US20070099227A1 (en) * 2004-10-12 2007-05-03 Curry Bo U Significance analysis using data smoothing with shaped response functions
US20060078898A1 (en) * 2004-10-12 2006-04-13 Curry Bo U Methods and compositions for reducing label variation in array-based comparative genome hybridization assays II
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
US20060110744A1 (en) 2004-11-23 2006-05-25 Sampas Nicolas M Probe design methods and microarrays for comparative genomic hybridization and location analysis
DE602006018861D1 (de) 2005-01-27 2011-01-27 Quest Diagnostics Invest Inc Schnelle komparative genomhybridisierung
US20060172314A1 (en) * 2005-01-31 2006-08-03 Song Min-Sun Quantification of amplified nucleic acids
US7541144B2 (en) * 2005-01-31 2009-06-02 Agilent Technologies, Inc. RNA labeling method
US20060173635A1 (en) * 2005-02-01 2006-08-03 Yakhini Zohar H Analyzing and visualizing enrichment in DNA sequence alterations
US20060192570A1 (en) * 2005-02-15 2006-08-31 Mann & Hummel Gmbh Apparatus for monitoring consumable parts
JP5744371B2 (ja) * 2005-02-22 2015-07-08 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 脊髄小脳性運動失調５型に関する遺伝子の同定、及び使用方法。
WO2007044071A2 (fr) 2005-04-21 2007-04-19 Exact Sciences Corporation Analyse d'echantillons d'acide nucleique heterogenes
US7544471B2 (en) 2005-07-30 2009-06-09 Agilent Technologies, Inc. Preparing RNA from a wax-embedded tissue specimen
US20070048743A1 (en) * 2005-08-26 2007-03-01 Sampas Nicholas M Methods and compositions for assessing candidate aCGH probe nucleic acids
US20070087355A1 (en) * 2005-10-14 2007-04-19 Barrett Michael T Comparative genomic hybridization assays and compositions for practicing the same
US8076074B2 (en) 2005-11-29 2011-12-13 Quest Diagnostics Investments Incorporated Balanced translocation in comparative hybridization
US11306351B2 (en) 2005-12-21 2022-04-19 Affymetrix, Inc. Methods for genotyping
US20070231803A1 (en) * 2006-03-31 2007-10-04 Jensen Mark A Multiplex pcr mixtures and kits containing the same
US8058055B2 (en) 2006-04-07 2011-11-15 Agilent Technologies, Inc. High resolution chromosomal mapping
US20070238106A1 (en) * 2006-04-07 2007-10-11 Agilent Technologies, Inc. Systems and methods of determining alleles and/or copy numbers
US20070238108A1 (en) * 2006-04-07 2007-10-11 Agilent Technologies, Inc. Validation of comparative genomic hybridization
US20070238104A1 (en) * 2006-04-07 2007-10-11 Agilent Technologies, Inc. Competitive oligonucleotides
US20080058218A1 (en) * 2006-05-03 2008-03-06 Gordon David B Arrays of compound probes and methods using the same
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
US20070259347A1 (en) * 2006-05-03 2007-11-08 Agilent Technologies, Inc. Methods of increasing the effective probe densities of arrays
US20070259345A1 (en) * 2006-05-03 2007-11-08 Agilent Technologies, Inc. Target determination using compound probes
US20070259346A1 (en) * 2006-05-03 2007-11-08 Agilent Technologies, Inc. Analysis of arrays
US20070259344A1 (en) * 2006-05-03 2007-11-08 Agilent Technologies, Inc. Compound probes and methods of increasing the effective probe densities of arrays
US7437249B2 (en) 2006-06-30 2008-10-14 Agilent Technologies, Inc. Methods and systems for detrending signal intensity data from chemical arrays
CA2656315A1 (fr) * 2006-06-30 2008-01-10 Nugen Technologies, Inc. Procedes de fragmentation et de marquage d'acides nucleiques
WO2008028044A2 (fr) 2006-08-30 2008-03-06 Centocor, Inc. Marqueurs et procédés pour évaluer et traiter la recto-colite hémorragique et des troubles associés utilisant un panel de 66 gènes
US8077951B2 (en) 2006-10-12 2011-12-13 Agilent Technologies, Inc. Method and system for dynamic, automated detection of outlying feature and feature background regions during processing of data scanned from a chemical array
US7881876B2 (en) 2006-10-12 2011-02-01 Agilent Technologies, Inc. Methods and systems for removing offset bias in chemical array data
US20080090236A1 (en) * 2006-10-13 2008-04-17 Yakhini Zohar H Methods and systems for identifying tumor progression in comparative genomic hybridization data
US20080102453A1 (en) * 2006-10-31 2008-05-01 Jayati Ghosh Methods and systems and analysis of CGH data
WO2008102606A1 (fr) 2007-01-31 2008-08-28 Wako Pure Chemical Industries, Ltd. Procede de detection d'une amplification ou d'une deletion dans un fragment d'adn genomique
US20080241829A1 (en) * 2007-04-02 2008-10-02 Milligan Stephen B Methods And Kits For Producing Labeled Target Nucleic Acid For Use In Array Based Hybridization Applications
US8200440B2 (en) 2007-05-18 2012-06-12 Affymetrix, Inc. System, method, and computer software product for genotype determination using probe array data
US20080293589A1 (en) * 2007-05-24 2008-11-27 Affymetrix, Inc. Multiplex locus specific amplification
US7507539B2 (en) 2007-07-30 2009-03-24 Quest Diagnostics Investments Incorporated Substractive single label comparative hybridization
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
US20090075835A1 (en) * 2007-09-17 2009-03-19 Signature Genomics Laboratories, Llc Methods and systems for the detection of microdeletion and microduplication syndromes
WO2009039589A1 (fr) 2007-09-28 2009-04-02 Murdoch Childrens Research Institute Procédé de détection, de suivi et d'isolement de cellules
US20090088330A1 (en) * 2007-09-28 2009-04-02 Leproust Emily M Methods And Kits For Producing Labeled Target Nucleic Acids For Use In Array Based Hybridization Applications
US8093063B2 (en) 2007-11-29 2012-01-10 Quest Diagnostics Investments Incorporated Assay for detecting genetic abnormalities in genomic nucleic acids
US7964354B2 (en) 2007-12-20 2011-06-21 Celgene Corporation Use of micro-RNA as a biomarker of immunomodulatory drug activity
CA2734519C (fr) 2008-08-29 2018-11-13 Centocor Ortho Biotech Inc. Marqueurs et procedes pour evaluer et pour traiter une recto-colite hemorragique et des troubles associes a l'aide d'un ensemble de 20 genes
US20100104513A1 (en) * 2008-10-28 2010-04-29 General Electric Company Method and system for dye assessment
AU2009313999B2 (en) * 2008-11-12 2016-09-29 Lineagen, Inc. Autism associated genetic markers
EP2436387B1 (fr) 2009-05-25 2018-07-25 Celgene Corporation Composition pharmaceutique contenant crbn et son utilisation dans le traitement des maladies du cortex cerebral.
WO2010138912A1 (fr) 2009-05-29 2010-12-02 Ventana Medical Systems, Inc. Méthodes de dénombrement du nombre de copies de gène dans un échantillon biologique à l'aide d'une hybridation in situ
WO2010138908A1 (fr) 2009-05-29 2010-12-02 Ventana Medical Systems, Inc. Nombre de copies du gène igf1r en tant que marqueur pronostique dans un cancer du poumon non à petites cellules
WO2011038360A1 (fr) 2009-09-25 2011-03-31 Signature Genomics Laboratories Llc Réseaux à brins multiplexes (+/-) et essais pour détecter des anomalies chromosomiques associées au cancer et autres maladies
WO2011048495A1 (fr) 2009-10-19 2011-04-28 Stichting Het Nederlands Kanker Instituut Prévision du bénéfice d'un traitement anti-cancer par une hybridation génomique comparative sur puce
WO2011048498A2 (fr) 2009-10-19 2011-04-28 Stichting Het Nederlands Kanker Instituut Différenciation de tumeurs associées à brca2 et de tumeurs sporadiques par hybridation génomique comparative par jeux ordonnés d'échantillons
WO2011048499A1 (fr) 2009-10-19 2011-04-28 Stichting Het Nederlands Kanker Instituut Prédiction d'une réaction à un traitement contre le cancer par hybridation génomique comparative par jeux ordonnés d'échantillons
WO2011056505A1 (fr) 2009-10-26 2011-05-12 Abbott Laboratories Détection d'anomalies chromosomiques associées au pronostic du cancer broncho-pulmonaire à grandes cellules
CA2785656A1 (fr) 2009-12-29 2011-07-07 Cancer Genetics, Inc. Outil de diagnostic et de pronostic de tumeurs a lymphocytes b matures
EP2519647A1 (fr) 2009-12-31 2012-11-07 Ventana Medical Systems, Inc. Procédés de production de sondes d'acide nucléique à spécificité unique
US9587278B2 (en) 2010-01-08 2017-03-07 Oxford Gene Technology (Operations) Ltd. Combined CGH and allele specific hybridisation method
US8774488B2 (en) 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
CA2798190A1 (fr) 2010-05-10 2011-11-17 Abbott Laboratories Detection d'anomalies chromosomiques associees a cancer de l'endometre
BR112012032217A2 (pt) 2010-06-15 2016-10-25 Celgene Corp métodos de predição de se um paciente será responsivo a um tratamento para psoríase, para monitorar a resposta de paciente a um tratamento para psoríase e para monitorar a aceitação do paciente por um protocolo de tratamento com droga para psoríase
EP2591433A4 (fr) * 2010-07-06 2017-05-17 Life Technologies Corporation Systèmes et procédés pour détecter une variation de nombre de copies
CN103392182B (zh) 2010-08-02 2017-07-04 众有生物有限公司 用于发现遗传疾病中致病突变的系统和方法
WO2012038837A2 (fr) 2010-09-20 2012-03-29 Stichting Het Nederlands Kanker Instituut Procédés de prévision d'une réponse à une thérapie anticancéreuse chez des patients cancéreux
EP2702410A2 (fr) 2011-04-29 2014-03-05 Celgene Corporation Procédés de traitement du cancer et de maladies inflammatoires au moyen de céréblon en tant que prédicteur
US20150087539A1 (en) 2011-07-14 2015-03-26 Traslational Cancer Drugs Pharma, S.L. Method for predicting outcome of cancer in a subject
WO2013041684A1 (fr) 2011-09-23 2013-03-28 Academisch Medisch Centrum Matériels et procédés de pronostic de la progression de l'œsophage de barrett
US10221454B2 (en) 2011-10-10 2019-03-05 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
WO2013055911A1 (fr) 2011-10-14 2013-04-18 Dana-Farber Cancer Institute, Inc. Biomarqueur znf365/zfp365 pouvant prévoir une réponse anticancéreuse
WO2013059746A1 (fr) 2011-10-19 2013-04-25 Nugen Technologies, Inc. Compositions et procédés pour l'amplification et le séquençage directionnels d'acide nucléique
US9121051B2 (en) 2011-10-31 2015-09-01 Arkray, Inc. Method of determining the abundance of a target nucleotide sequence of a gene of interest
WO2013067451A2 (fr) 2011-11-04 2013-05-10 Population Diagnostics Inc. Méthodes et compositions pour le diagnostic, le pronostic et le traitement d'états neurologiques
TWI455461B (zh) * 2011-11-23 2014-10-01 Delta Electronics Inc 冷卻套
EP2788768A1 (fr) 2011-12-10 2014-10-15 Abbott Molecular Inc. Agents et méthodes de diagnostic du mélanome malin et de pronostic des métastases du mélanome malin
EP2794915B1 (fr) 2011-12-22 2017-02-08 Centre National de la Recherche Scientifique (CNRS) Procédé de détection adn et quantification par hybridation et manipulation à molécule simple
EP2798080B1 (fr) 2011-12-30 2019-02-20 Abbott Molecular Inc. Matériels et méthodes pour le diagnostic et le pronostic d'un cancer pancréato-biliaire
EP2798079B1 (fr) 2011-12-30 2016-09-07 Abbott Molecular Inc. Matériels et méthodes pour le diagnostic du cancer de la vessie et la surveillance de la récidive de celui-ci
JP6203752B2 (ja) 2011-12-30 2017-09-27 アボツト・モレキユラー・インコーポレイテツド 前立腺癌の治療／予防処置の診断、予測及び評価のための材料及び方法
SG11201404243WA (en) 2012-01-26 2014-08-28 Nugen Technologies Inc Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
DK2812452T3 (da) 2012-02-09 2020-06-29 Population Bio Inc Fremgangsmåder og sammensætninger til screening og behandling af udviklingsforstyrrelser
WO2013124740A2 (fr) 2012-02-23 2013-08-29 Stichting Vu-Vumc Dysfonctionnement de la protéine brca et signatures arnm utiles dans l'identification de patients atteints de tumeurs dues au dysfonctionnement de la protéine brca et prévision des bénéfices d'une thérapie anti-cancer sur des patients atteints de cancer
WO2013167387A1 (fr) 2012-05-10 2013-11-14 Ventana Medical Systems, Inc. Sondes spécifiques uniques pour pten, pik3ca, met, top2a et mdm2
ITMI20120846A1 (it) 2012-05-16 2013-11-17 Bongulielmi Reto Metodo e sistema per valutare molecole in campioni biologici tramite immagini derivate da microarray
EP2861787B1 (fr) 2012-06-18 2017-09-20 Nugen Technologies, Inc. Compositions et procédés pour la sélection négative de séquences d'acide nucléique indésirable
EP3904875B1 (fr) 2012-06-29 2024-11-20 Celgene Corporation Procédés pour déterminer l'efficacité d'un médicament en utilisant ikzf3 (aiolos)
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US9587281B2 (en) 2012-08-14 2017-03-07 Celgene Corporation Cereblon isoforms and their use as biomarkers for therapeutic treatment
US9976180B2 (en) 2012-09-14 2018-05-22 Population Bio, Inc. Methods for detecting a genetic variation in subjects with parkinsonism
WO2014048942A1 (fr) 2012-09-25 2014-04-03 Ventana Medical Systems, Inc. Sondes pour pten, pik3ca, met et top2a, et procédés d'utilisation de ces sondes
WO2014052855A1 (fr) 2012-09-27 2014-04-03 Population Diagnostics, Inc. Procédés et compositions de dépistage et de traitement de troubles du développement
PL2914296T5 (pl) 2012-11-01 2022-01-17 Infinity Pharmaceuticals, Inc. Leczenie nowotworu z zastosowaniem modulatorów izoform kinazy PI3
WO2014159791A1 (fr) 2013-03-14 2014-10-02 Abbott Molecular Inc. Matériaux et méthodes pour l'évaluation d'un adénome colo-rectal
US20140274738A1 (en) 2013-03-15 2014-09-18 Nugen Technologies, Inc. Sequential sequencing
US20140377258A1 (en) 2013-05-30 2014-12-25 Infinity Pharmaceuticals, Inc. Treatment Of Cancers Using PI3 Kinase Isoform Modulators
EP2813571A1 (fr) 2013-06-13 2014-12-17 Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Procédé pour le traitement du cancer du poumon
US11104950B2 (en) 2013-09-11 2021-08-31 The Regents Of The University Of California Human blood molecular biodosimeter panel for distinguishing radiation exposure from inflammation stress
DK3511422T3 (da) 2013-11-12 2023-02-06 Population Bio Inc Fremgangsmåder og sammensætninger til diagnosticering, prognose og behandling af endometriose
US9546399B2 (en) 2013-11-13 2017-01-17 Nugen Technologies, Inc. Compositions and methods for identification of a duplicate sequencing read
JP6573611B2 (ja) 2013-12-06 2019-09-11 セルジーン コーポレイション びまん性大細胞型ｂ細胞リンパ腫、多発性骨髄腫、及び骨髄癌の治療の薬効を決定するための方法
WO2015131107A1 (fr) 2014-02-28 2015-09-03 Nugen Technologies, Inc. Séquençage au bisulfite de représentation réduite avec adaptateurs de diversité
US11624093B2 (en) 2014-04-24 2023-04-11 Dana-Farber Cancer Institute, Inc. Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
US10092555B2 (en) 2014-06-27 2018-10-09 Celgene Corporation Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
US9994912B2 (en) 2014-07-03 2018-06-12 Abbott Molecular Inc. Materials and methods for assessing progression of prostate cancer
CA2996445A1 (fr) 2014-09-05 2016-03-10 Eli Hatchwell Methodes et compositions destinees a inhiber et a traiter des etats neurologiques
EP3204516B1 (fr) 2014-10-06 2023-04-26 Dana-Farber Cancer Institute, Inc. Biomarqueurs à base d'angiopoïétine -2 utilisés pour la prédiction de la réponse de point de contrôle anti-immunitaire
CA2963602A1 (fr) 2014-10-09 2016-04-14 Dana-Farber Cancer Institute, Inc. Schema posologique d'il-2 variables multiples pour le traitement de troubles immunitaires
JP2017533733A (ja) 2014-11-11 2017-11-16 アボツト・モレキユラー・インコーポレイテツド ハイブリダイゼーションプローブおよび方法
US10948492B2 (en) 2015-03-06 2021-03-16 Dana-Farber Cancer Institute, Inc. PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers
EP3109324B1 (fr) * 2015-06-23 2018-09-19 ZytoVision GmbH Procede de detection d'aberrations chromosomiques
EP3385395B9 (fr) 2015-08-17 2020-05-20 Kura Oncology, Inc. Méthodes de traitement de patients cancéreux à l'aide d'inhibiteurs de farnésyltransférases
WO2017117118A1 (fr) 2015-12-28 2017-07-06 Celgene Corporation Compositions et méthodes pour induire des modifications conformationnelles dans céréblon et d'autres ubiquitine ligases e3
JP6880037B2 (ja) 2016-01-08 2021-06-02 セルジーン コーポレイション がんの治療方法と、治療法に対する臨床的感度の予測因子としてのバイオマーカーの使用
US20190119758A1 (en) 2016-04-22 2019-04-25 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
AU2017332721B2 (en) 2016-09-20 2023-11-09 Sara BUHRLAGE Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators
US11124839B2 (en) 2016-11-03 2021-09-21 Kura Oncology, Inc. Methods of treating cancer patients with farnesyltransferase inhibitors
EP3577459A4 (fr) 2017-02-03 2020-12-16 Celgene Corporation Procédés de mesure de l'affinité de petites molécules pour le céréblon
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
US9956215B1 (en) 2017-02-21 2018-05-01 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
SG11201907594TA (en) 2017-02-21 2019-09-27 Kura Oncology Inc Methods of treating cancer with farnesyltransferase inhibitors
US11820822B2 (en) 2017-06-06 2023-11-21 Dana-Farber Cancer Institute, Inc. Methods for sensitizing cancer cells to T cell-mediated killing by modulating molecular pathways
EP3664804A4 (fr) 2017-08-07 2021-04-14 Kura Oncology, Inc. Méthodes de traitement du cancer avec des inhibiteurs de la farnésyltransférase
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
WO2019125184A1 (fr) 2017-12-19 2019-06-27 Auckland Uniservices Limited Utilisation de biomarqueur en thérapie du cancer
EP3759125A4 (fr) 2018-02-28 2021-12-08 Dana-Farber Cancer Institute, Inc. Méthodes de traitement du cancer à l'aide de combinaisons d'agents de blocage anti-btnl2 et points de contrôle immunitaires
BR112020015999A2 (pt) 2018-04-06 2020-12-15 Dana-Farber Cancer Institute, Inc. Kir3dl3 como um receptor de hhla2, anticorpos anti-hhla2 e usos dos mesmos
WO2019226770A1 (fr) 2018-05-23 2019-11-28 Celgene Corporation Traitement du myélome multiple et utilisation de biomarqueurs pour le 4-(4-(4-(((2-(2,6-dioxopipéridin-3-yl)-1-oxoisoindolin-4-yl)oxy)méthyl)benzyl)pipérazin-1-yl)-3-fluorobenzonitrile
AU2019316556C9 (en) 2018-08-08 2025-04-10 Pml Screening, Llc Methods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing
CN113286591A (zh) 2018-11-01 2021-08-20 库拉肿瘤学公司 用法尼基转移酶抑制剂治疗癌症的方法
WO2020180663A1 (fr) 2019-03-01 2020-09-10 Kura Oncology, Inc. Méthodes de traitement du cancer à l'aide d'inhibiteurs de farnésyltransférase
KR20210144778A (ko) 2019-03-29 2021-11-30 쿠라 온콜로지, 인크. 파르네실트랜스퍼라제 억제제를 사용한 편평 세포 암종의 치료 방법
WO2020205387A1 (fr) 2019-04-01 2020-10-08 Kura Oncology, Inc. Méthodes de traitement du cancer à l'aide d'inhibiteurs de la farnésyltransférase
US20220289854A1 (en) 2019-04-30 2022-09-15 Dana-Farber Cancer Institute, Inc. Methods for treating cancer using combinations of anti-cx3cr1 and immune checkpoint blockade agents
WO2020223583A1 (fr) 2019-05-02 2020-11-05 Kura Oncology, Inc. Méthodes de traitement de la leucémie myéloïde aiguë avec des inhibiteurs de la farnésyltransférase
US20230075965A1 (en) 2020-01-24 2023-03-09 Constantine S. Mitsiades Uses of biomarkers for improving immunotherapy
US12059674B2 (en) 2020-02-03 2024-08-13 Tecan Genomics, Inc. Reagent storage system
MX2023010238A (es) 2021-03-02 2023-12-05 Dana Farber Cancer Inst Inc Métodos para tratar trastornos de glóbulos rojos.
US20240280561A1 (en) 2021-06-08 2024-08-22 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
WO2023097119A2 (fr) 2021-11-29 2023-06-01 Dana-Farber Cancer Institute, Inc. Méthodes et compositions pour moduler riok2
JP2025513822A (ja) 2022-04-15 2025-04-30 セルジーン コーポレーション 薬物に対するリンパ腫の応答性を予測する方法及びリンパ腫を治療する方法
WO2025034542A1 (fr) 2023-08-04 2025-02-13 Cornell University Panel de signature génique prédisant une réponse cancéreuse à un blocage de point de contrôle immunitaire et radiothérapie

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422956A1 (fr) * 1978-04-13 1979-11-09 Pasteur Institut Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US4681840A (en) * 1984-01-18 1987-07-21 The United States Of America As Represented By The Secretary Of Commerce Deoxyribonucleic acid molecules useful as probes for detecting oncogenes incorporated into chromosomal DNA
US4707440A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Nucleic acid hybridization assay and detectable molecules useful in such assay
US4710465A (en) * 1984-04-19 1987-12-01 Yale University Junction-fragment DNA probes and probe clusters
US4647529A (en) * 1984-06-01 1987-03-03 Rodland Karin D Hybridization method of detecting nucleic acid sequences with probe containing thionucleotide
US4666828A (en) * 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4721669A (en) * 1985-01-18 1988-01-26 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4772691A (en) * 1985-06-05 1988-09-20 The Medical College Of Wisconsin, Inc. Chemically cleavable nucleotides
US4725536A (en) * 1985-09-19 1988-02-16 Genetics Institute, Inc. Reagent polynucleotide complex with multiple target binding regions, and kit and methods
US4888278A (en) * 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US4770992A (en) * 1985-11-27 1988-09-13 Den Engh Gerrit J Van Detection of specific DNA sequences by flow cytometry
US5447841A (en) * 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US5721098A (en) * 1986-01-16 1998-02-24 The Regents Of The University Of California Comparative genomic hybridization
WO1987005027A1 (fr) * 1986-02-21 1987-08-27 Whitehead Institute For Biomedical Research Sondes d'hybridation de l'adn specifique du chromosome y et procedes d'utilisation desdites sondes
US5348855A (en) * 1986-03-05 1994-09-20 Miles Inc. Assay for nucleic acid sequences in an unpurified sample
CA1284931C (fr) 1986-03-13 1991-06-18 Henry A. Erlich Procede de detection de variations specifiques de nucleotides et de polymorphismes genetiques dans les acides nucleiques
US4981783A (en) * 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US5085983A (en) * 1988-08-19 1992-02-04 City Of Hope Detection of human tumor progression and drug resistance
US5194300A (en) * 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
JP2589729B2 (ja) * 1988-01-30 1997-03-12 極東製薬工業株式会社 染色体ｄｎａを用いた細菌の同定方法および該同定用キット
US5064948A (en) * 1988-02-12 1991-11-12 The United States Of America As Represented By The Department Of Energy Chromosome specific repetitive dna sequences
WO1990005789A1 (fr) * 1988-11-15 1990-05-31 Yale University Hybridation par suppression in situ et utilisations
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
GB8920211D0 (en) 1989-09-07 1989-10-18 Ici Plc Diagnostic method
AU647741B2 (en) * 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining
US5427932A (en) * 1991-04-09 1995-06-27 Reagents Of The University Of California Repeat sequence chromosome specific nucleic acid probes and methods of preparing and using
US5965362A (en) * 1992-03-04 1999-10-12 The Regents Of The University Of California Comparative genomic hybridization (CGH)
JP3645903B2 (ja) * 1992-03-04 2005-05-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 比較ゲノムハイブリダイゼーション（ｃｇｈ）
US5840484A (en) 1992-07-17 1998-11-24 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
US5472842A (en) * 1993-10-06 1995-12-05 The Regents Of The University Of California Detection of amplified or deleted chromosomal regions
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays

Also Published As

Publication number Publication date
DE69330750D1 (de) 2001-10-18
EP1134293A2 (fr) 2001-09-19
JP3645903B2 (ja) 2005-05-11
US7537895B2 (en) 2009-05-26
US20060292608A1 (en) 2006-12-28
CA2131543A1 (fr) 1993-09-16
EP0631635A1 (fr) 1995-01-04
CA2131543C (fr) 2002-09-17
EP0631635B1 (fr) 2001-09-12
JPH07505053A (ja) 1995-06-08
US5665549A (en) 1997-09-09
US7238484B2 (en) 2007-07-03
DE69330750T2 (de) 2002-07-04
ES2161715T3 (es) 2001-12-16
EP1134293A3 (fr) 2004-01-07
WO1993018186A1 (fr) 1993-09-16
US20050118634A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
ATE205542T1 (de) Vergleichende genomhybridisierung
Zietkiewicz et al. Genome fingerprinting by simple sequence repeat (SSR)-anchored polymerase chain reaction amplification
Grunau et al. Large-scale methylation analysis of human genomic DNA reveals tissue-specific differences between the methylation profiles of genes and pseudogenes
Raine et al. SPlinted Ligation Adapter Tagging (SPLAT), a novel library preparation method for whole genome bisulphite sequencing
DK0800587T3 (da) Komparativ hybridisering af nukleinsyrerækker
JP6484177B2 (ja) 多重核酸検出方法
WO2000040755A3 (fr) Acceleration de l'identification des polymorphismes d'un nucleotide unique et alignement de clones dans le sequençage genomique
ATE201451T1 (de) Multiple genomische dna-verstärkung zum nachweis einer deletion
ATE288474T1 (de) Ataxia-telangiectasia gen und dessen genomische organisation
Guldberg et al. Single‐step DGGE‐based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer
CA2163740A1 (fr) Detection directe de sequences repetees de nucleotides dans le genome humain
ATE196169T1 (de) Nachweis von treponema pallidum und haemophilus ducreyi
CA2366374C (fr) Methode de detection et/ou d'analyse, au moyen de techniques d'amorce extensives, de polymorphismes a nucleotide unique dans des fragments restrictifs, en particulier dans des fragments restrictifs amplifies produits au moyen d'aflp
EP1002130A1 (fr) Amorces permettant d'obtenir des marqueurs d'adn
AU1204600A (en) Systems and methods for sequencing by hybridization
US5032502A (en) Purification of polymorphic components of complex genomes
ATE396258T1 (de) Methode zum parallelen auffinden von insertionsmutanten und reagentien um dies zu bewerkstelligen
HUANG et al. Fidelity and predominant mutations produced by deep vent wild-type and exonuclease-deficient DNA polymerases during in vitro DNA amplification
Hutter et al. Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell lines
El‐Maarri et al. Intron 22‐specific long PCR for the Xba I polymorphism in the factor VIII gene
WO1989002440A3 (fr) Sondes d'hybridation a adn specifiques a l'y et utilisations prevues a cet effet
Fischel-Ghodsian et al. Rapid detection of the hemoglobin C mutation by allele-specific polymerase chain reaction
CA2392673A1 (fr) Hybridation genomique comparative (hgc)
Wagner et al. Mismatch binding protein-based mutation detection systems
US20080044916A1 (en) Computational selection of probes for localizing chromosome breakpoints

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties